The impact of glucagon-like peptide-1 receptor agonists (GLP-1Ra) on bone health remains unclear
Increased Energy and Wellness With weight loss often comes increased energy levels, improved mobility, and a greater sense of well-being, empowering you to live your life to the fullest
Any side effects should also go away, but speak to your doctor if they do not
Only a head-to-head trial can prove it (Endpoints) Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead (Reuters) Immunovant's FcRn drug fails in a pair of Phase 3 trials in thyroid eye disease (Endpoints) Exclusive: OpenEvidence moves into prior authorization and prescriptions routing (Endpoints) Alto Neuroscience shelves schizophrenia cognitive impairment program after Phase 2 miss (Endpoints) Gilead ends a Phase 2/3 trial of long-acting HIV pills, following earlier clinical hold (Endpoints) AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial (Reuters) Medtech Beyond detection: In the age of clinical AI, what counts as an FDA breakthrough medical device
Frequently Asked Questions Is glutathione safe for all dogs
Proponents of GLP-1 agonists highlight the drugs effectiveness in curbing appetite and promoting weight loss, while opponents argue the drugs come with serious side effects and cost too much to make a dent in the obesity crisis
